+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Ulcerative Colitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Xerostomia - Pipeline Insight, 2025 - Product Thumbnail Image

Xerostomia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Xlinked Severe Combined Immunodeficiency (SCID) - Pipeline Insight, 2025 - Product Thumbnail Image

Xlinked Severe Combined Immunodeficiency (SCID) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sanfilippo Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Sanfilippo Syndrome- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sporadic Inclusion Body Myositis (sIBM) - Pipeline Insight, 2025 - Product Thumbnail Image

Sporadic Inclusion Body Myositis (sIBM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Localized Scleroderma - Pipeline Insight, 2025 - Product Thumbnail Image

Localized Scleroderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lyme Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Lyme Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Mucopolysaccharidosis I - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis I - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Papulopustular Rosacea- Pipeline Insight, 2025 - Product Thumbnail Image

Papulopustular Rosacea- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chemokine Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Chemokine Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
interleukin Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

interleukin Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Toll-Like Receptor Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-Like Receptor Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Chronic Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Psoriatic Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Uveitis - Pipeline Insight, 2025 - Product Thumbnail Image

Uveitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alopecia - Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Hizentra Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

Hizentra Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more